Q1 FY2025 Earnings
Financial report interval: 2024.12.31 - 2025.03.31
Overview: Akoya Biosciences(AKYA) the Revenue is 16.64 M (-9.32%);the EBIT is -13.27 M (+22.14%);the EPS is -0.315 (+33.99%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.02B9.32%
----
----
EBIT
-0.01B22.14%
----
----
EPS
-0.315233.99%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf